ADHD stimulant medications carry small psychosis risk, but far lower than feared
When properly monitored, ADHD stimulants cause psychosis in just 0.2 to 3 percent of users.
Reported by The ConversationClaims checked against the source, 8 h ago.
ShareWhy it matters
Understanding the real risk helps patients and doctors make informed decisions without panic or unnecessary avoidance.
In Australia. Nearly 600,000 Australians are prescribed ADHD stimulants. Clear facts about psychosis risk help people stay on effective treatment rather than stopping out of fear.
Key facts
- 0.2 to 3 percent
- Psychosis risk range
- 220,000 teenagers and young adults
- US study size
- from 2 to 22 per 1,000 people
- Australian diagnosis increase 2004-2024
- 2 in every 1,000
- Diagnosis prevalence in Australia 2004
- Several alarming reports this year warned that Australians were developing psychosis from ADHD stimulant medications like methylphenidate (Ritalin, Concerta) and amphetamines (Vyvanse).
- The real risk is small when properly monitored.
- Between 0.2 and 3 percent of people taking them develop psychotic symptoms.
- One US study tracked more than 220,000 teenagers and young adults.
- It found about 1 in 660 developed psychosis after starting the drugs.
- The risk is actually lower than with other common medications such as oral steroids used for asthma.
- ADHD diagnoses in Australia have surged.
- They jumped from 2 in every 1,000 people in 2004 to 22 in 1,000 by 2024.
- The medications work by boosting dopamine and focus.
- Research shows they reduce serious harms including car accidents, substance misuse and criminal convictions.


